The pharmaceutical industry's chemical synthesis is starting to change thanks to enzyme catalysis, which is made possible by developments in protein engineering and guided evolution. The pharmaceutical sector has recognised the growing significance of catalysis. A crucial technology that allows affordable and ecologically friendly industrial processes is catalysis. The creation of a workable catalytic process for industrial scales is a challenging challenge that necessitates cross-disciplinary cooperation. The pharmaceutical sector has recognised the growing significance of catalysis. A crucial technology that allows affordable and ecologically friendly industrial processes is catalysis. The creation of a workable catalytic process for industrial scales is a challenging challenge that necessitates cross-disciplinary cooperation.
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model via design-driven bio- and chemical engineering view of biotech
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Application of metal single-site zeolite catalysts in heterogeneous catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Use of iron nanomaterials for the treatment of metals, metalloids and emergent contaminants in water
Marta I Litter, University of General San Martin, Argentina
Title : One-pot multicomponent syntheses of functional chromophores – Synthetic efficiency meets functionality design
Thomas J J Muller, Heinrich-Heine-Universitat Dusseldorf, Germany
Title : From photocatalysis to photon-phonon co-driven catalysis for inert molecules activation
Junwang Tang, Tsinghua University, China
Title : Antibody-proteases as a generation of unique biomarkers, potential targets and translational tools towards design-driven bio- and chemical engineering and personalized and precision medical practice
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico